Cargando…
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
The treatment of World Health Organization (WHO) grades 2 and 3 meningiomas remains difficult and controversial. The pathogenesis of high-grade meningiomas was expected to be elucidated to improve treatment strategies. The molecular biology of meningiomas has been clarified in recent years. High-gra...
Autores principales: | OKANO, Atsushi, MIYAWAKI, Satoru, TERANISHI, Yu, OHARA, Kenta, HONGO, Hiroki, SAKAI, Yu, ISHIGAMI, Daiichiro, NAKATOMI, Hirofumi, SAITO, Nobuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464479/ https://www.ncbi.nlm.nih.gov/pubmed/35871574 http://dx.doi.org/10.2176/jns-nmc.2022-0114 |
Ejemplares similares
-
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas
por: Sakai, Yu, et al.
Publicado: (2022) -
Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index
por: Teranishi, Yu, et al.
Publicado: (2022) -
Meningiomas in patients with neurofibromatosis type 2 predominantly comprise ‘immunogenic subtype’ tumours characterised by macrophage infiltration
por: Teranishi, Yu, et al.
Publicado: (2023) -
Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges
por: Okano, Atsushi, et al.
Publicado: (2021) -
Differences in Clinical Features among Different Onset Patterns in Moyamoya Disease
por: Hirano, Yudai, et al.
Publicado: (2021)